Oncology firm Yellowstone Biosciences has chosen the ARC Oxford science campus as its first home.
The firm was spun out of the University of Oxford in June with support from Oxford University Innovation. It has launched with £16.5m secured in
Syncona-backed oncology start-up picks ARC Oxford
